Method for determining the estrogen receptor status of breast cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9075061
APP PUB NO 20120046199A1
SERIAL NO

13138847

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a method for determining the estrogen receptor status of patients suffering from breast cancer. The present invention also aims to provide methods and devices for predicting the response of patients diagnosed with breast cancer to specific medicaments. More specifically, the present invention provides methods which measure kinase activity by studying phosphorylation levels and profiles in samples obtained from patients diagnosed with breast cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PAMGENE B V5211 HH 'S-HERTOGENBOSCH

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Foekens, Johannes Albert Capelle a/d IJssel, NL 4 17
Hilhorst, Maria Helena Wageningen, NL 8 64
Martens, Johannes Wilhelmus Maria Rotterdam, NL 1 6
Ruijtenbeek, Robby Utrecht, NL 17 45
Umar, Arzu Rotterdam, NL 1 6

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 7, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00